BS

Binney Street Capital

North America, Massachusetts, United States, Boston

Description

Binney Street Capital is a venture fund associated with the Dana-Farber Cancer Institute in Boston.

Investor Profile

Binney Street Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Biopharma
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Binney Street Capital frequently co-invest with?

Alexandria
North America, California, United States, San Francisco
Co-Investments: 1
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Sixty Degree Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 3
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
AbbVie
North America, Illinois, United States, North Chicago
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2

Which angels does Binney Street Capital often collaborate with?

GF
North America, California, United States
Shared Deals: 2

What are some of recent deals done by Binney Street Capital?

NextPoint Therapeutics

Cambridge, Massachusetts, United States

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BFeb 14, 2024
Amount Raised: $42,500,000
Precede Biosciences

Boston, Massachusetts, United States

Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw.

BiopharmaBiotechnologyHealth Care
Series AOct 5, 2023
Amount Raised: $57,000,000
NextPoint Therapeutics

Cambridge, Massachusetts, United States

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BJan 10, 2023
Amount Raised: $80,000,000
Kojin Therapeutics

Cambridge, Massachusetts, United States

Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.

BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series AJun 9, 2021
Amount Raised: $60,000,000